atipamezole has been researched along with oxazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audinot, V; Boutin, JA; Cordi, A; Cussac, D; Dekeyne, A; Duqueyroix, D; Girardon, S; Lacoste, JM; Millan, MJ; Milligan, G; Mullot, J; Newman-Tancredi, A; Nicolas, JP; Renouard-Try, A | 1 |
| Auclair, A; Bosc, C; Brocco, M; Cordi, A; Dekeyne, A; Gobert, A; Lacoste, JM; Lejeune, F; Millan, MJ; Rivet, JM | 1 |
2 other study(ies) available for atipamezole and oxazoles
| Article | Year |
|---|---|
S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Animals; Body Temperature; CHO Cells; Clonidine; Cricetinae; Dexmedetomidine; Humans; Imidazoles; Imidazoline Receptors; Male; Mice; Oxazoles; Rats; Rats, Wistar; Receptors, Drug | 2000 |
S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Anti-Anxiety Agents; Biogenic Monoamines; Clonidine; Dexmedetomidine; Imidazoles; Locus Coeruleus; Male; Mice; Motor Activity; Oxazoles; Raphe Nuclei; Rats; Rats, Wistar; Ventral Tegmental Area; Vocalization, Animal | 2000 |